Geneos Wealth Management Inc. V Tv Therapeutics Inc. Transaction History

Geneos Wealth Management Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 May 19, 2021	SELL	$1.49 - $3.1 $1,490 - $3,100	-1,000 Closed	0 $0
Q3 2020 Sep 07, 2021	BUY	$1.7 - $2.98 $1,700 - $2,980	1,000 New	1,000 $1,000
Q1 2020 Sep 07, 2021	SELL	$1.63 - $3.75 $4,074 - $9,375	-2,500 Closed	0 $0
Q4 2019 Sep 07, 2021	SELL	$1.37 - $1.97 $1,370 - $1,970	-1,000 Reduced 28.57%	2,500 $4,000
Q4 2018 Sep 07, 2021	SELL	$0.78 - $3.74 $1,170 - $5,610	-1,500 Reduced 30.0%	3,500 $7,000

Q2 2018 Sep 07, 2021	BUY	$0.71 - $4.04 $3,550 - $20,200	5,000 New	5,000 $7,000

243K

Ticker VTVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,483,600
Market Cap $1.43B
Description
vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on the development of orally administered treatments for diabetes. The company is developing TTP399, an orally administered, small molecule, and liver-selective glucokinase activator for the treatment of type 1 diabetes; and HPP737, an orally administered non-CNS penetran...

Get notified when there are updates to the investment portfolio of Geneos Wealth Management Inc., based on Form 13F filings with the SEC.

Stay updated on Geneos Wealth Management Inc. with notifications on news.